Christophe Schilling is the founder and CEO of Genomatica. He is also the chairman of Biocom, the largest advocacy organization for California’s life sciences sector, and serves on BIO’s Industrial & Environmental Section Governing Board. He previously served on the World Economic Forum Global Agenda Council on Biotechnology. Christophe holds a Ph.D. in bioengineering from the University of California, San Diego and earned a B.S. in biomedical engineering from Duke University.